Physician profile
Yaron B Gesthalter
NPI 1013183599
$13,521.68
in general payments reported to CMS, 2019-2025
9 companies · $3,512 in 2025
The $3,512 reported for 2025 was more than what 91% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,139 · 2020: $1.39 · 2021: $335 · 2022: $400 · 2023: $3,784 · 2024: $2,351 · 2025: $3,512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,500 · Food and Beverage: $1,461 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Travel and Lodging: $686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,500.00 |
| Food and Beverage | $1,460.71 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Travel and Lodging | $685.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,305.89 | 2019-2025 | Ion, Da Vinci Surgical System |
| Pulmonx Corporation | $2,027.72 | 2019-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Pinnacle Biologics, INC | $1,529.52 | 2019 | |
| Bard Peripheral Vascular, INC. | $241.77 | 2025 | Pleurx |
| Boston Scientific Corporation | $167.95 | 2024-2025 | General - Therapies |
| Atricure, INC. | $136.57 | 2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Olympus America INC. | $89.34 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $21.53 | 2023 | Tezspire |
| Veran Medical Technologies, INC. | $1.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yaron Gesthalter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.